Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00928057 · ClinicalTrials.gov registry record · NA
Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles
A NA study, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
NCT00928057 is a NA study that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 173 participants.
The verdict
NCT00928057, a NA study, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
Study Summary
Anxiety about needles is a commonly expressed concern by diabetics about beginning insulin therapy. A shorter, thinner pen needle that delivers insulin with the safety and efficacy profile of currently marketed pen needles may appeal to many diabetic patients as the new needle may be perceived as less intimidating and more comfortable. Currently marketed pen needles range in length from 5 to 12.7 millimeters (mm). The primary purpose of this study was to evaluate whether the investigational 4mm x 32 Gauge(G) pen needle manufactured by Becton, Dickinson and Company (BD) provides equivalent glucose control (as measured by fructosamine levels) as the currently marketed BD 5mm x 31 G and BD 8mm x 31 G pen needles (PN)in diabetic subjects with varying insulin dosage regimens.
Interventions
- DEVICE 4mm x 32G pen needle
- DEVICE 8mm x 31G pen needle
- DEVICE 5mm x 31G pen needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00928057
The ClinicalTrials.gov registry entry for NCT00928057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 4mm x 32G pen needle is the first listed.
NCT00928057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00928057 about?
NCT00928057 is a clinical study titled "Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles". Anxiety about needles is a commonly expressed concern by diabetics about beginning insulin therapy. A shorter, thinner pen needle that delivers insulin with the safety and efficacy profile of currently marketed pen needles may appeal to many diabetic patients as the new needle may be perceived as le...
What is the current status of trial NCT00928057?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2009-06. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00928057?
The interventions under investigation include: 4mm x 32G pen needle (DEVICE), 8mm x 31G pen needle (DEVICE), 5mm x 31G pen needle (DEVICE).
Who is sponsoring clinical trial NCT00928057?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.